NEW YORK, July 7, 2015 /PRNewswire/ -- BCC Researchs goal in conducting this study is to determine the current status of the DNA diagnostics industry and to assess its growth potential over a five-year period from 2015 to 2020.
Use this report to:
- Receive comprehensive analysis of the current molecular diagnostics market and its future direction.
- Analyze developments and their impact on the DNA diagnostics business.
- Evaluate scientific challenges and advances including the latest trends in molecular diagnostics market.
- The global molecular diagnostics market was valued at almost $21.7 billion in 2014. The total market is projected to grow at a compound annual growth rate (CAGR) of 12.5% from 2015 through 2020 to reach nearly $25.2 billion by 2015 and $45.2 billion by 2020.
- The market for polymerase chain reaction (PCR)-based diagnostic assays totaled nearly $10.1 billion in 2014. This market is projected to grow at a CAGR of 11.1% from 2015 to 2020, to reach nearly $11.5 billion by 2015 and $19.4 billion by 2020.
- The biochip or lab-on-a-chip market totaled nearly $2.5 billion in 2014. It is projected to increase at a CAGR of 16.5% to reach $3 billion by 2015 and nearly $6.5 billion by 2020.
Introduction & Scope
STUDY GOALS AND OBJECTIVES
BCC Research's goal in conducting this study is to determine the current status of the DNA diagnostics industry and to assess its growth potential over a five-year period
from 2015 to 2020. We are particularly interested in the markets for DNA microarrays, polymerase chain reaction (PCR)-based assays, fluorescent in situ hybridization and
biochips. In addition, we are interested in the market for DNA assays for specific clinical applications. For each we examine the technology, development process, market penetration and projected market for each diagnostic assay through 2020. Our key objective is to present a comprehensive analysis of the current market and its
REASONS FOR DOING THE STUDY
DNA-based assays continue to move from research settings into the clinic; therefore, they represent one of the fastest-growing segments of diagnostics. We are interested
in the innovations in microarrays, PCR assays, biochips and other common technologies for DNA detection as they are modified for routine clinical use. As nucleic
acid testing becomes routine, a number of related issues have come to the fore, including government regulation, reimbursement through insurance, and patient confidentiality and other legal ramifications. These developments and their impact on the DNA diagnostics business are also covered in this report.
SCOPE OF REPORT
This study examines the global market for assays used to detect specific nucleic acid sequences in medical and life sciences applications. While the goal of all DNA-based
diagnostic assays is similar, several different technologies can be employed. BCC Research analyzes each technology in detail, determines major players and current
market status and presents forecasts of growth over the next five years. Scientific challenges and advances including the latest trends are emphasized. We examine
government regulations, major collaborations, recent patents and factors affecting the industry globally. In addition, we examine new directions for DNA diagnostic
technologies and emerging applications in clinical diagnostics.
This study will be of interest to technology and business professionals in the pharmaceutical, healthcare, genomics and biotechnology industries. Business development professionals, market analysts, consultants and investors working in medical biotechnology will also find this report valuable.
METHODOLOGY AND INFORMATION SOURCES
The market assessments provided have been assembled based on publicly available information up to and including April 2015. The base year for this report is 2010 and
forecast data are provided through 2020. Market figures are based on current dollars, and inflation is not computed into the projection figures. The information contained in
this report has been assembled from both primary and secondary data sources. Primary research was conducted via telephone interviews with industry professionals,
research scientists, physician-researchers and laboratory heads to discover the most recent developments in their fields of interest. Secondary data were collected via a
comprehensive search of the peer-reviewed scientific literature, clinical trial reports and databases, industry trade media, company websites, annual reports and industry
Read the full report: http://www.reportlinker.com/p01140654-summary/view-report.html
ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: firstname.lastname@example.org
Intl: +1 339-368-6001